Necrotic Enteritis in Poultry: Etiology, Pathogenesis, Diagnosis, and Control
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Necrotic Enteritis (NE) in poultry is primarily caused by Clostridium perfringens, a Gram-positive anaerobic bacterium, with the NetB toxin being the principal virulence factor responsible for enterocyte lysis and mucosal necrosis.
- Coccidiosis, particularly infection with Eimeria species, is the most significant predisposing factor for NE, as it damages the intestinal mucosa and creates a favorable environment for C. perfringens proliferation.
- Diagnosis relies on characteristic gross lesions (e.g., "Turkish towel" appearance of the mucosa), histopathology showing coagulative necrosis, and laboratory confirmation via PCR for the NetB toxin gene.
- Control strategies are multifactorial, emphasizing strict biosecurity, effective coccidiosis management (vaccination or anticoccidials), and nutritional adjustments to reduce available substrates for C. perfringens.
- Alternative therapeutic and control measures are gaining prominence due to reduced antibiotic use, including probiotics, bacteriophages, organic acids, phytogenics, and novel vaccine development targeting key virulence factors like NetB.
What is Necrotic Enteritis
Necrotic enteritis (NE) is an acute, often fatal enteric disease of poultry, primarily affecting broiler chickens, caused by the anaerobic, spore-forming bacterium Clostridium perfringens [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. The disease is characterized by severe, focal to diffuse necrosis of the intestinal mucosa, leading to significant economic losses in the poultry industry due to increased mortality, reduced growth performance, and increased feed conversion ratios [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Understanding what is necrotic enteritis requires a detailed examination of its multifactorial etiology, complex pathogenesis, and the interplay between host, pathogen, and environmental factors [<a href="#ref-3">3</a>, <a href="#ref-7">7</a>, <a href="#ref-8">8</a>].
Etiology
The primary etiological agent of NE is Clostridium perfringens, a Gram-positive, rod-shaped, anaerobic bacterium capable of producing many extracellular toxins [<a href="#ref-3">3</a>, <a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. While C. perfringens is a normal inhabitant of the intestinal microbiota of healthy poultry at low levels, specific predisposing factors allow for its massive proliferation and the subsequent expression of key virulence factors [<a href="#ref-1">1</a>, <a href="#ref-7">7</a>, <a href="#ref-11">11</a>].
Toxinotypes and Virulence Factors
C. perfringens is classified into toxinotypes (A through G) based on the production of major toxins (alpha, beta, epsilon, iota, and NetB) [<a href="#ref-3">3</a>, <a href="#ref-9">9</a>]. For decades, NE was primarily associated with type A strains producing alpha-toxin (CPA). However, the discovery of the NetB toxin (Necrotic Enteritis B-like toxin) was a pivotal advancement [<a href="#ref-10">10</a>]. NetB is a pore-forming toxin that is now considered the primary virulence factor for NE in poultry, leading to the classification of NE-associated strains as type G [<a href="#ref-3">3</a>, <a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. The NetB toxin causes the formation of pores in the plasma membrane of host enterocytes, leading to osmotic lysis and cell death, which is the direct cause of the characteristic mucosal necrosis [<a href="#ref-3">3</a>, <a href="#ref-10">10</a>].
Other virulence factors contribute to the pathogenesis. Alpha-toxin, a phospholipase C, possesses hemolytic and necrotic activities and may act synergistically with NetB [<a href="#ref-3">3</a>, <a href="#ref-12">12</a>]. Additionally, C. perfringens produces a range of enzymes, including collagenase, hyaluronidase, and sialidase, which facilitate tissue degradation and bacterial spread within the intestinal lamina propria [<a href="#ref-3">3</a>]. The ability to form biofilms is another important trait, enhancing bacterial survival and persistence in the environment and within the host [<a href="#ref-12">12</a>].
Predisposing Factors
The transition of C. perfringens from a commensal organism to a pathogen is dependent on specific predisposing factors that disrupt the normal intestinal ecosystem [<a href="#ref-3">3</a>, <a href="#ref-8">8</a>].
Coccidiosis: Infection with Eimeria species is the most significant predisposing factor for NE [<a href="#ref-3">3</a>, <a href="#ref-8">8</a>]. Coccidial replication within enterocytes causes mucosal damage, leading to the leakage of plasma proteins and nutrients into the intestinal lumen. This protein-rich environment provides an ideal substrate for the rapid proliferation of C. perfringens [<a href="#ref-3">3</a>, <a href="#ref-8">8</a>].
Diet: Dietary composition plays a critical role. High levels of crude protein, particularly those containing high amounts of indigestible proteins (e.g., fishmeal, soybean meal), increase the availability of substrates for C. perfringens in the distal ileum [<a href="#ref-5">5</a>, <a href="#ref-11">11</a>]. Diets based on barley or wheat, which are high in non-starch polysaccharides (NSPs), increase digesta viscosity, slowing transit time and promoting bacterial overgrowth [<a href="#ref-11">11</a>].
Immunosuppression: Factors that compromise the immune system, such as infectious bursal disease virus or mycotoxin contamination of feed, can increase susceptibility to NE [<a href="#ref-3">3</a>].
Epidemiology
NE occurs worldwide and is considered one of the most economically important bacterial diseases of poultry [<a href="#ref-1">1</a>, <a href="#ref-13">13</a>]. The disease is most commonly seen in broiler chickens between 2 and 6 weeks of age, although it can also affect layers and turkeys [<a href="#ref-2">2</a>, <a href="#ref-7">7</a>]. The incidence of NE has increased significantly following the global trend of reducing or banning the use of in-feed antibiotic growth promoters (AGPs), which previously provided effective prophylaxis [<a href="#ref-8">8</a>, <a href="#ref-13">13</a>].
The epidemiology of NE is closely linked to the presence of C. perfringens spores in the environment [<a href="#ref-7">7</a>]. Spores are highly resistant and can persist in poultry houses, litter, feed, and water, serving as a continuous source of infection for subsequent flocks [<a href="#ref-7">7</a>]. Molecular epidemiological studies using pulsed-field gel electrophoresis (PFGE) and rpoB sequence typing have revealed a high degree of genetic diversity among C. perfringens isolates from different farms and regions, although certain clones may be more frequently associated with disease [<a href="#ref-2">2</a>, <a href="#ref-14">14</a>]. The spore load in the environment has been correlated with the occurrence of NE outbreaks on farms [<a href="#ref-7">7</a>].
Pathogenesis
The pathogenesis of NE is a sequential, multifactorial process. The initial step involves the disruption of the intestinal mucosal barrier, most commonly by Eimeria spp. [<a href="#ref-3">3</a>, <a href="#ref-8">8</a>]. This damage exposes the underlying connective tissue and provides a rich source of amino acids and peptides for C. perfringens [<a href="#ref-3">3</a>]. Concurrently, dietary factors such as high NSP levels increase digesta viscosity, creating a favorable environment for anaerobic bacterial growth [<a href="#ref-11">11</a>].
As C. perfringens populations expand, they upregulate the production of virulence factors, most critically the NetB toxin [<a href="#ref-10">10</a>]. NetB inserts into the enterocyte membrane, forming heptameric pores that disrupt ion gradients, leading to cell swelling and oncotic necrosis [<a href="#ref-3">3</a>]. The combined action of NetB, CPA, and other degradative enzymes results in the characteristic coagulative necrosis of the villi and the formation of a diphtheritic membrane composed of fibrin, necrotic cells, and bacteria [<a href="#ref-3">3</a>, <a href="#ref-10">10</a>]. The loss of absorptive surface area and the systemic effects of absorbed toxins lead to the clinical signs of the disease.
Clinical Signs
NE can present in two main forms: clinical and subclinical.
Clinical Necrotic Enteritis: This acute form is characterized by a sudden increase in flock mortality, often without premonitory signs [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. Affected birds appear depressed, huddle together, and exhibit ruffled feathers. Diarrhea is common, often described as dark, tarry, or mucoid [<a href="#ref-3">3</a>]. Morbidity and mortality can be high, with mortality rates reaching 10-50% in untreated flocks [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>].
Subclinical Necrotic Enteritis: This form is more insidious and economically damaging. Birds do not show overt clinical signs but suffer from chronic damage to the intestinal mucosa [<a href="#ref-15">15</a>, <a href="#ref-16">16</a>]. This results in poor nutrient absorption, leading to reduced weight gain, increased feed conversion ratio, and flock unevenness [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>, <a href="#ref-16">16</a>]. Subclinical NE is often undiagnosed but contributes significantly to production losses.
Pathology
Gross pathological lesions are primarily confined to the small intestine, particularly the jejunum and ileum [<a href="#ref-3">3</a>, <a href="#ref-10">10</a>]. The intestinal wall is typically thin, friable, and distended with gas and fluid. The hallmark lesion is the presence of a characteristic "Turkish towel" appearance, where the mucosa is covered by a yellow-brown, necrotic, diphtheritic membrane [<a href="#ref-3">3</a>, <a href="#ref-10">10</a>]. This membrane is often loosely attached and can be easily removed, revealing a hemorrhagic and ulcerated mucosal surface.
Microscopically, the lesions are characterized by severe coagulative necrosis of the villi, with massive infiltration of heterophils and fibrin [<a href="#ref-3">3</a>]. Large numbers of Gram-positive rod-shaped bacteria are often visible within the necrotic debris and adhering to the mucosal surface [<a href="#ref-10">10</a>].
Diagnosis
A definitive diagnosis of NE is based on a combination of clinical signs, gross pathology, histopathology, and laboratory confirmation of C. perfringens and its toxins [<a href="#ref-3">3</a>, <a href="#ref-10">10</a>].
Necropsy and Histopathology
The presence of the characteristic gross lesions in the small intestine is highly suggestive of NE [<a href="#ref-3">3</a>, <a href="#ref-10">10</a>]. Histopathological examination of affected intestinal sections confirms the diagnosis by demonstrating coagulative necrosis, fibrin deposition, and the presence of Gram-positive rods [<a href="#ref-3">3</a>].
Microbiological Culture and Isolation
C. perfringens can be isolated from intestinal scrapings or liver samples by anaerobic culture on selective media (e.g., Tryptose Sulfite Cycloserine agar) [<a href="#ref-10">10</a>, <a href="#ref-17">17</a>]. However, isolation alone is not diagnostic, as C. perfringens is a normal inhabitant of the gut. Quantification of C. perfringens levels (e.g., >10^6 CFU/g of intestinal content) can support a diagnosis of NE [<a href="#ref-1">1</a>, <a href="#ref-7">7</a>].
Toxin Detection and Genotyping
Detection of the NetB toxin gene by polymerase chain reaction (PCR) is the gold standard for confirming the presence of pathogenic type G strains [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. PCR can be performed directly on intestinal contents or on cultured isolates. Toxinotyping can also be performed using multiplex PCR to differentiate between toxinotypes [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. Sequencing of the NetB gene can provide further epidemiological information [<a href="#ref-10">10</a>].
Molecular Epidemiology
Advanced molecular typing methods, such as PFGE and rpoB sequence typing, are used for epidemiological investigations to track the spread of specific C. perfringens clones within and between flocks [<a href="#ref-2">2</a>, <a href="#ref-14">14</a>].
Biomarkers
Recent research has explored the use of fecal acute-phase proteins as non-invasive biomarkers for monitoring NE in broiler flocks [<a href="#ref-18">18</a>].
The following decision tree summarizes the diagnostic approach for NE.
graph TD
A["Suspicion of Necrotic Enteritis"] --> B{"Clinical Signs & Mortality?"};
B -->|"Yes"| C["Perform Necropsy"];
B -->|"No"| D["Monitor for Subclinical Signs"];
C --> E{"Gross Lesions in Jejunum/Ileum?"};
E -->|"Yes (Turkish towel appearance)"| F["Collect Intestinal Scrapings & Liver"];
E -->|"No"| G["Consider Other Enteric Diseases"];
F --> H["Anaerobic Culture & Gram Stain"];
H --> I["Quantify C. perfringens"];
I --> J["PCR for NetB & Toxin Genes"];
J --> K["Histopathology"];
K --> L["Confirm NE Diagnosis"];
D --> M["Assess Performance Data (FCR, BW)"];
M --> N["Fecal Sampling for Biomarkers & PCR"];
N --> O["Subclinical NE Diagnosis"];Treatment
Treatment of clinical NE is challenging due to the rapid course of the disease. Historically, in-feed antibiotics such as bacitracin methylene disalicylate, virginiamycin, and lincomycin were used for treatment and prevention [<a href="#ref-13">13</a>]. However, with the global push to reduce antimicrobial use, alternative strategies are being developed and implemented [<a href="#ref-13">13</a>, <a href="#ref-19">19</a>].
Antimicrobial Therapy
In regions where it is still permitted, water-soluble antibiotics (e.g., amoxicillin, tylosin) can be administered to treat acute outbreaks [<a href="#ref-3">3</a>, <a href="#ref-20">20</a>]. However, antimicrobial susceptibility testing (AST) is critical to guide therapy, as resistance to commonly used antibiotics is increasing [<a href="#ref-17">17</a>, <a href="#ref-20">20</a>]. The agar dilution and broth microdilution methods are standard techniques for AST of C. perfringens [<a href="#ref-17">17</a>].
Alternative Therapeutic Strategies
many alternatives to conventional antibiotics are under investigation.
Probiotics and Direct-Fed Microbials: Bacillus species (e.g., B. subtilis, B. velezensis) and Enterococcus faecium have shown efficacy in reducing C. perfringens colonization and NE severity by competing for nutrients, producing antimicrobial metabolites, and modulating the gut microbiota [<a href="#ref-21">21</a>, <a href="#ref-22">22</a>, <a href="#ref-23">23</a>, <a href="#ref-24">24</a>]. Lactobacillus species and their postbiotics also improve intestinal health and growth performance in NE-challenged birds [<a href="#ref-15">15</a>, <a href="#ref-25">25</a>].
Bacteriophages: Lytic bacteriophages specific to C. perfringens offer a targeted approach to reduce pathogen load. Phage cocktails designed to overcome cross-resistance have shown promise in mitigating NE [<a href="#ref-9">9</a>, <a href="#ref-26">26</a>, <a href="#ref-27">27</a>].
Organic Acids and Phytogenics: Dietary supplementation with organic acids (e.g., benzoic acid, butyric acid) and phytogenic feed additives (e.g., cinnamon essential oil, thymol, Balanites aegyptiaca extracts) can improve gut health, reduce C. perfringens counts, and attenuate NE-associated damage [<a href="#ref-4">4</a>, <a href="#ref-6">6</a>, <a href="#ref-12">12</a>, <a href="#ref-19">19</a>, <a href="#ref-28">28</a>]. Glycerol monolaurate has also been shown to attenuate NE by improving gut-liver health [<a href="#ref-29">29</a>].
Nanoparticles: Chitosan nanoparticles have demonstrated in vivo antibacterial activity against C. perfringens-induced NE [<a href="#ref-30">30</a>].
Control
Effective control of NE requires an integrated approach that addresses the multifactorial nature of the disease [<a href="#ref-3">3</a>, <a href="#ref-13">13</a>].
Management and Biosecurity
Strict biosecurity measures are essential to minimize the introduction and spread of C. perfringens spores [<a href="#ref-7">7</a>]. This includes thorough cleaning and disinfection of poultry houses between flocks, with a focus on removing organic matter that can protect spores [<a href="#ref-7">7</a>]. Litter management is critical; wet litter promotes coccidiosis and C. perfringens proliferation [<a href="#ref-3">3</a>, <a href="#ref-8">8</a>].
Nutritional Strategies
Dietary manipulation is a cornerstone of NE control. Formulating diets with lower crude protein levels and optimized amino acid ratios reduces the substrate available for C. perfringens in the gut [<a href="#ref-5">5</a>]. Supplementation with exogenous enzymes (e.g., xylanase) reduces digesta viscosity in wheat- or barley-based diets, thereby limiting bacterial overgrowth [<a href="#ref-11">11</a>, <a href="#ref-16">16</a>].
Coccidiosis Control
Effective control of coccidiosis is paramount for preventing NE [<a href="#ref-3">3</a>, <a href="#ref-8">8</a>]. This can be achieved through the use of anticoccidial drugs (ionophores or chemicals) or vaccination with live Eimeria vaccines [<a href="#ref-8">8</a>]. The phase-out of ionophores in some regions has been linked to an increased incidence of NE, highlighting the importance of integrated coccidiosis management [<a href="#ref-8">8</a>].
Vaccination
Considerable research is focused on developing effective vaccines against NE. Strategies include the use of recombinant NetB and other non-toxin antigens (e.g., FimB, CnaA, FBA) delivered via live vectors such as attenuated Salmonella or Lactobacillus [<a href="#ref-31">31</a>, <a href="#ref-32">32</a>, <a href="#ref-33">33</a>, <a href="#ref-34">34</a>]. Multi-epitope vaccines designed using pangenome-based strategies are also being explored [<a href="#ref-31">31</a>]. Oral immunization with these vectors aims to induce a protective mucosal immune response against C. perfringens [<a href="#ref-32">32</a>, <a href="#ref-33">33</a>, <a href="#ref-34">34</a>].
Microbiome Modulation
Modulating the gut microbiota through the use of probiotics, prebiotics, and specific bacterial strains (e.g., Bacteroides thetaiotaomicron) is a promising strategy to enhance colonization resistance against C. perfringens [<a href="#ref-1">1</a>, <a href="#ref-15">15</a>, <a href="#ref-21">21</a>, <a href="#ref-35">35</a>]. These approaches aim to restore a healthy microbial ecosystem that is less permissive to pathogen overgrowth.